DON'T MISS OUT!
Phase 3 Clinical Trial For Alzheimer's Disease Underway Free Webinar to Learn More
Please Pass On This Exciting News!
Link to above
To Register for the webinar click here
In an area where an effective disease-modifying therapy greatly needed, Professor Wischik is on the verge of becoming an overnight success — 30-plus years in the making — if the Phase III trials for LMTX®, the second-generation tau aggregation inhibitor (TAI), prove to be as successful as the Phase II trials of its predecessor, rember®.
Don't forget you can go watch this webinar anytime now! Please pass it on to those who might be interested. Clinical trials are important to us all in the long run, even if we are not touched by dementia today, it could easily come into our life or hit someone we love or work with tomorrow.
